Ronald Erasio Lusikooy

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Blood-Based vs. Tissue-Based mRNA Expression of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, and Methylenetetrahydrofolate Reductase: A Prospective Study to Predict the Neoadjuvant CAPEOX Response in Advanced Colorectal Cancer.

|May 22, 2026
Predictive Value of Serum MTHFR and CEA Levels for Tumor Size Reduction Following Neoadjuvant CAPEOX Therapy in Advanced Colorectal Cancer Patients in Makassar.

|Feb 09, 2026
Towards Precision Oncology: A Predictive Nomogram Incorporating DPD and MTHFR for CapeOX Neoadjuvant Chemotherapy in Colorectal Cancer.

Elvida Christy Imelda Tahiya, Ronald Erasio Lusikooy, Ilhamjaya Pattelongi

|Oct 28, 2025
Validation of Platelet-index based Score (PIBS) for Early Prediction of the Pathological Stage in Colorectal Cancer.

Adi Madethen, Ronald Erasio Lusikooy, Julianus Aboyaman Uwuratuw

|Apr 30, 2025
Development and Validation of Platelet-Index Based Colorectal Cancer Survival Prognostic Nomogram.

Erwin Syarifuddin, Warsinggih Raharjo, Rina Masadah

|Dec 29, 2024
Development and Validation of Machine Learning Model Platelet Index-based Predictor for Colorectal Cancer Stage.

Citra Aryanti, Ronald Erasio Lusikooy, Samuel Sampetoding

Pageof 1

Frequent Collaborators

5 joint publications

Erwin Syarifuddin

4 joint publications

Citra Aryanti

4 joint publications

Samuel Sampetoding

4 joint publications

Warsinggih Warsinggih